Jerusalem Pharmaceutical Co (XPAE:JPH) E10: $0.20 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAE:JPH Jerusalem Pharmaceutical Co XPAE:JPH
82 GF Score
Price $3.57
GF Value $2.41
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Jerusalem Pharmaceutical Co E10?

Jerusalem Pharmaceutical Co XPAE:JPH 82 E10 is $0.20 as of Mar. 2026. GuruFocus rates XPAE:JPH with a GF Score™ of 82/100 and a GF Value™ of $2.41 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Jerusalem Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was $0.060. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $0.20 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Jerusalem Pharmaceutical Co's average E10 Growth Rate was 17.60% per year. During the past 3 years, the average E10 Growth Rate was 8.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Jerusalem Pharmaceutical Co was 8.20% per year. The lowest was 8.20% per year. And the median was 8.20% per year.

As of today (2026-07-28), Jerusalem Pharmaceutical Co's current stock price is $3.57. Jerusalem Pharmaceutical Co's E10 for the quarter that ended in Mar. 2026 was $0.20. Jerusalem Pharmaceutical Co's Shiller PE Ratio of today is 17.85.

During the past 13 years, the highest Shiller PE Ratio of Jerusalem Pharmaceutical Co was 19.45. The lowest was 10.88. And the median was 11.84.


Jerusalem Pharmaceutical Co  (XPAE:JPH) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Jerusalem Pharmaceutical Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=3.57/0.20
=17.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Jerusalem Pharmaceutical Co was 19.45. The lowest was 10.88. And the median was 11.84.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Jerusalem Pharmaceutical Co E10 Related Terms


Jerusalem Pharmaceutical Co E10 Historical Data

* Premium members only.

The historical data trend for Jerusalem Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jerusalem Pharmaceutical Co E10 Chart

Jerusalem Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.15 0.16 0.17 0.19

Jerusalem Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.17 0.18 0.18 0.19 0.20

XPAE:JPH vs ZTS, UTHR, VTRS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Jerusalem Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jerusalem Pharmaceutical Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Jerusalem Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Jerusalem Pharmaceutical Co's Shiller PE Ratio falls into.


XPAE:JPH
82GF Score
Jerusalem Pharmaceutical Co XPAE:JPH
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jerusalem Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Jerusalem Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.06/330.2130*330.2130
=0.060

Current CPI (Mar. 2026) = 330.2130.

Jerusalem Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201606 0.033 241.018 0.045
201609 0.033 241.428 0.045
201612 0.034 241.432 0.047
201703 0.046 243.801 0.062
201706 0.038 244.955 0.051
201709 0.036 246.819 0.048
201712 0.052 246.524 0.070
201803 0.032 249.554 0.042
201806 0.043 251.989 0.056
201809 0.042 252.439 0.055
201812 0.036 251.233 0.047
201903 0.021 254.202 0.027
201906 0.025 256.143 0.032
201909 0.030 256.759 0.039
201912 0.072 256.974 0.093
202003 0.034 258.115 0.043
202006 -0.003 257.797 -0.004
202009 0.036 260.280 0.046
202012 0.037 260.474 0.047
202103 0.024 264.877 0.030
202106 0.010 271.696 0.012
202109 0.048 274.310 0.058
202112 0.102 278.802 0.121
202203 0.037 287.504 0.042
202206 0.032 296.311 0.036
202209 0.046 296.808 0.051
202212 0.086 296.797 0.096
202303 0.041 301.836 0.045
202306 0.042 305.109 0.045
202309 0.067 307.789 0.072
202312 0.044 306.746 0.047
202403 0.008 312.332 0.008
202406 0.027 314.175 0.028
202409 0.037 315.301 0.039
202412 0.070 315.605 0.073
202503 0.059 319.799 0.061
202506 0.051 322.561 0.052
202509 0.095 324.800 0.097
202512 0.079 324.054 0.081
202603 0.060 330.213 0.060

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of $0.20 mean?
Jerusalem Pharmaceutical Co (XPAE:JPH) has a E10 of $0.20 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Jerusalem Pharmaceutical Co and its competitors.
Is Jerusalem Pharmaceutical Co's E10 too high?
Jerusalem Pharmaceutical Co's current E10 is $0.20. Overall, Jerusalem Pharmaceutical Co has a GF Score™ of 82/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Jerusalem Pharmaceutical Co's E10 compare to ZTS and UTHR?
Jerusalem Pharmaceutical Co's E10 of $0.20 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Jerusalem Pharmaceutical Co and its competitors. Jerusalem Pharmaceutical Co's current E10 is $0.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jerusalem Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Jerusalem Pharmaceutical Co (XPAE:JPH) is currently considered Significantly Overvalued. The stock's GF Value™ is $2.41, compared to a current price of $3.57 — trading 48.1% above its estimated fair value. The current E10 is $0.20. Jerusalem Pharmaceutical Co's overall GF Score™ is 82/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Jerusalem Pharmaceutical Co (XPAE:JPH), the current E10 is $0.20 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jerusalem Pharmaceutical Co (XPAE:JPH) Overvalued in 2026?

Based on GuruFocus' analysis, Jerusalem Pharmaceutical Co stock appears to be overvalued. The current stock price of $3.57 is trading 48.1% above its estimated GF Value™ of $2.41. GuruFocus considers Jerusalem Pharmaceutical Co to be Significantly Overvalued.

Key valuation signals for XPAE:JPH:

  • E10: $0.20
  • GF Value™: $2.41 vs. price of $3.57 (48.1% above fair value)
  • GF Score™: 82/100 with 6 warning signs

No single metric tells the full story. See the XPAE:JPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Jerusalem Pharmaceutical Co Business Description

Address Nablus Street, Jerusalem Pharmaceuticals Company Buliding, Al Bireh Industrial Zone, Al Bireh, PSE, 3570
Jerusalem Pharmaceutical Co is engaged in developing, manufacturing and marketing of human pharmaceuticals products. It also produces detergent, cosmetic, personal and home care products, veterinary and agricultural products. The company operates in Jordan, Algeria, the Middle East, and North Africa Region. Its product portfolio contains more than 300 pharmaceutical products in various dosage forms including tablets, capsules, sterile injectables, powders for suspensions, suspensions, syrups, powders, suppositories, ovules, creams, ointments, as well as ear and nose drops and solutions.
82GF Score

Get the complete analysis for XPAE:JPH

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.57
Price
$2.41
GF Value